DRAUPNIR BIO

Draupnir Bio intends to develop a new type of cholesterol-lowering medicine that prevents blood clots in the heart more effectively than the current medicine. The company is developing a platform for exploring the glycome to develop novel therapeutics, based on array technology, protein chemistry, and advanced carbohydrate chemistry. The company is able to synthesize, screen, and select highly potent and specific heparan sulfate glycomimetic drug candidates in cardiovascular, inflammatory, and infectious diseases.

#SimilarOrganizations #People #Financial #Website #More

DRAUPNIR BIO

Industry:

Biotechnology Health Care Pharmaceutical Therapeutics

Founded:

2017-01-01

Address:

Risskov, Midtjylland, Denmark

Country:

Denmark

Website Url:

http://www.draupnir.bio

Total Employee:

10001+

Status:

Active

Total Funding:

33 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Amazon

Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

not_available_image

Lay Line Genomics S.p.A.

Lay Line Genomics S.p.A. is the straight line tracing the course following which a boat can fetch an upwind mark

medigene-logo

MediGene

MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.

phico-therapeutics-logo

Phico Therapeutics

Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.

stoke-therapeutics-logo

Stoke Therapeutics

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment.

Current Employees Featured

andrew-hotchkiss_image

Andrew Hotchkiss
Andrew Hotchkiss Chief Executive Officer @ Draupnir Bio
Chief Executive Officer
2021-06-01

christine-ritter_image

Christine Ritter
Christine Ritter Operations Manager @ Draupnir Bio
Operations Manager
2020-09-01

anna-quattropani_image

Anna Quattropani
Anna Quattropani Chief Discovery Officer @ Draupnir Bio
Chief Discovery Officer
2021-07-01

Founder

simon-glerup_image

Simon Glerup

Investors List

high-tech-gründerfonds_image

High-Tech Grunderfonds

High-Tech Grunderfonds investment in Venture Round - Draupnir Bio

inkef-capital_image

Inkef

Inkef investment in Venture Round - Draupnir Bio

novo-a-s_image

Novo Holdings

Novo Holdings investment in Venture Round - Draupnir Bio

gilde-healthcare-partners_image

Gilde Healthcare

Gilde Healthcare investment in Venture Round - Draupnir Bio

Official Site Inspections

http://www.draupnir.bio

Host Informations
Whois Informations

Loading ...

More informations about "Draupnir Bio" on Search Engine